Coen Steven P. reported option exercise involving 587 shares of Ginkgo Bioworks Holdings, Inc. on May 21, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
See remarks
See remarks
Filed May 26, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
587Class A Common Stock
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
50,855Direct
Trade date
May 21, 2026Option exercise
Filed
May 26, 2026, 5:04 PM ET5-day reporting delay
Accession
0001628280-26-038202Code M · Transaction 385627
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 22, 2026Sell307$8.33−$2,558.54Trade 385629
May 21, 2026Option exercise587——Trade 385630
May 21, 2026Option exercise156——Trade 385631
May 21, 2026Option exercise156——Trade 385628
5 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

DNA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
DNA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −5.5%1w ago −9.7%1d ago −11%
Returns since7d +7.4%30d +10%90d −22%180d1y

Footnotes in full

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. F3: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F4: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.